SCHEMBL3230816

SCHEMBL3230816

CCC[CH]CNCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
DPP7 Q9UHL4 1/20 0.47
ADH1B P00325 1/20 0.44
ADH1C P00326 1/20 0.44
ADH1A P07327 1/20 0.44
ADH7 P40394 1/20 0.44
MAOA P21397 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 2/20 0.42
CHRM2 P08172 1/20 0.42
GAA P10253 1/20 0.42
CYP3A4 P08684 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9427392 0.89 MAOA (0.46) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL6664416 0.85 MEN1 (0.48) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL21574007 0.85 MEN1 (0.48) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL27877532 0.81 MEN1 (0.48) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL9735718 0.78 EPHX2 (0.52) MEN1KMT2ATDP1DPP7MAOA
SCHEMBL9735716 0.78 EPHX2 (0.52) MEN1KMT2ATDP1DPP7MAOA
SCHEMBL4065565 0.78 MEN1 (0.54) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL15607673 0.77 MEN1 (0.64) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL16869633 0.76 MEN1 (0.52) MEN1KMT2ATDP1DPP7ADH1B
SCHEMBL457444 0.76 MEN1 (0.52) MEN1KMT2ATDP1DPP7ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9211533-B2 Organic metal complex and process for preparing amine compound KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-12-15 US disclosed
EP-2228377-B1 Novel organometallic complex and process for preparing amine compound KANTO KAGAKU (JP) 2014-07-30 EP disclosed
US-8481735-B2 Organic metal complex and process for preparing amine compound KANTO KAGAKU KABUSHIKI KAISHA (JP) 2013-07-09 US disclosed
US-20100234596-A1 NOVEL ORGANIC METAL COMPLEX AND PROCESS FOR PREPARING AMINE COMPOUND KANTO KAGAKU KABUSHIKI KAISHA (JP) 2010-09-16 US disclosed
EP-2228377-A1 Novel organometallic complex and process for preparing amine compound Kanto Kagaku Kabushiki Kaisha (JP) 2010-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234596-A1 NOVEL ORGANIC METAL COMPLEX AND PROCESS FOR PREPARING AMINE COMPOUND ODC1, AOC2, AOC1 MEN1 508/4885KMT2A 636/4885TDP1 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.